The CHARM program consisted of 3 component trials, each comparing candesartan with placebo in a distinct population of patients with symptomatic heart failure [9]: CHARM-Alternative: patients with ...
Please provide your email address to receive an email when new articles are posted on . Researchers analyzed medical records of 50 adolescents treated at Texas Children’s Hospital Headache Clinic.
The angiotensin receptor blocker (ARB) candesartan is associated with superior neurocognitive outcomes compared with lisinopril in older adults with hypertension and mild cognitive impairment, a new ...
A single arm, multicenter, open-label phase II study of orally administered GW572016 as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results